CD28-B7 T-cell co-stimulatory blockade potentiates the effects of intrathymic immunomodulation in sensitized graft recipients

Transplantation

Volumn 64, Issue 12, 1997, Pages 1816-1822

  Stadlbauer, Thomas H W ^a   Schaub, Meike ^a   Korom, Stephan ^a   Onodera, Kazuhiko ^a   Sayegh, Mohamed H ^a   Kupiec Weglinski, Jerzy W ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; B7 ANTIGEN; CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; MONOCLONAL ANTIBODY;

ALLOGENEIC RESTRICTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; CELLULAR IMMUNITY; CONFERENCE PAPER; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTOTOXICITY; MALE; MIXED LYMPHOCYTE REACTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SENSITIZATION; T LYMPHOCYTE SUBPOPULATION; THYMUS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION; CYTOTOXICITY, IMMUNOLOGIC; GRAFT REJECTION; IMMUNOCONJUGATES; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; ISOANTIBODIES; LYMPHOCYTE CULTURE TEST, MIXED; MALE; RATS; RATS, INBRED BN; RATS, INBRED LEW; RATS, INBRED WF; SKIN TRANSPLANTATION; SURVIVAL ANALYSIS; T-LYMPHOCYTES; THYMUS GLAND;

EID: 0031435310     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199712270-00032     Document Type: Conference Paper

References (48)

1. Sanfilippo FP, Vaughn WK, Peters TG, et al. Factors affecting the waiting time of cadaveric kidney transplant candidates in the United States. JAMA 1992; 267: 247.
2. Binder J, Sayegh MH, Watschinger B, Hancock WW, Kupiec-Weglinski JW. Intrathymic injection of donor-specific x-irradiation-sensitive spleen cells abrogates accelerated rejection of cardiac allografts in sensitized rats. Transplantation 1994; 58: 80.
3. Binder J, Hancock WW, Watschinger B, Wasowska B, Sayegh MH, Kupiec-Weglinski JW. The alloantibody network following intrathymic immunomodulation of sensitized rat recipients of cardiac allografts. Transplantation 1995; 59: 590.
4. Binder J, Graser E, Hancock WW, et al. Downregulation of intragraft IFN-γ expression correlates with increased IgG1 alloantibody response following intrathymic immunomodulation of sensitized rat recipients. Transplantation 1995; 60: 1516.
5. Posselt AM, Barker CF, Tomaszewski JE, Markmann JF, Choti MA, Naji A. Induction of donor-specific unresponsiveness by intrathymic islet transplantation. Science 1990; 249: 1293.
6. Perico N, Rossini M, Imberti O, Remuzzi G. Evidence of the central role of the thymus in the induction of donor-specific unresponsiveness to a renal allograft. Transplantation 1992; 54: 943.
7. Remuzzi G, Rossini M, Imberti O, Perico N. Kidney graft survival in rats without immunosuppressants after intrathymic glomerular transplantation. Lancet 1991; 337: 750.
8. Sayegh MH, Perico N, Gallon L, et al. Mechanisms of acquired thymic unresponsiveness to renal allografts. Transplantation 1994; 58: 125.
9. Goss JA, Nakafusa Y, Yu S, Flye MW. Intrathymic injection of donor alloantigens induces specific tolerance to cardiac allografts. Transplantation 1993; 56: 166.
10. Oluwole SF, Chowdhury NC, Fawwaz RA. Induction of donor-specific unresponsiveness to rat cardiac allografts by intrathymic injection of UV-B-irradiated donor spleen cells. Transplantation 1993; 55: 1389.
11. Oluwole SF, Chowdhury NC, Fawwaz RA. Induction of donor-specific unresponsiveness to rat cardiac allografts by pretreatment with intrathymic donor MHC class I antigens. Transplantation 1993; 55: 1396.
12. Odorico JS, Barker CF, Posselt AM, Naji A. Induction of donor-specific tolerance to rat cardiac allografts by intrathymic inoculation of bone marrow. Surgery 1992; 112: 370.
13. Shimomura K, Hardy MA, Oluwole SF. Tolerance induction to cardiac allografts by simultaneous or sequential intrathymic inoculation of disparate alloantigens. Transplantation 1995; 60: 806.
14. Chowdhury NC, Fawwaz RA, Oluwole SF. Induction of donor-specific tolerance to rat cardiac and small bowel allografts by intrathymic inoculation of donor T-cells. J Surg Res 1993; 54: 368.
15. Campos L, Alfrey EJ, Posselt AM, Odorico JS, Barker CF, Naji A. Prolonged survival of rat orthotopic liver allografts after intrathymic inoculation of donor-strain cells. Transplantation 1993; 55: 866.
16. Ohzato H, Monaco AP. Induction of specific unresponsiveness (tolerance) to skin allografts by intrathymic donor-specific splenocyte injection in antilymphocyte serum-treated mice. Transplantation 1992; 54: 1090.
17. Markmann JF, Odorico JS, Bassiri H, Desai N, Kim JI, Barker CF. Deletion of donor-reactive T lymphocytes in adult mice after intrathymic inoculation with lymphoid cells. Transplantation 1993; 55: 871.
18. Bretscher P, Cohn M. A theory of self-nonself discrimination. Science 1970; 169: 1042.
19. Schwartz RH. Acquisition of immunologic self-tolerance. Cell 1989; 57: 1073.
20. Janeway CA Jr, Bottomly K. Signals and signs for lymphocyte responses. Cell 1994; 76: 275.
21. Linsley PS, Ledbetter JA. The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 1993; 11: 191.
22. Bluestone JA. New perspectives of CD28-B7-mediated T cell costimulation. Immunity 1995; 2: 555.
23. Thompson CB. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation. Cell 1995; 81: 879.
24. Turka LA, Linsley PS, Lin H, et al. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci USA 1992; 89: 11102.
25. Lin H, Bolling SF, Linsley PS, et al. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J Exp Med 1993; 178: 1801.
26. Russel ME, Hancock WW, Akalin E, et al. Chronic cardiac rejection in the Lewis to F344 model: blockade of CD 28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis. J Clin Invest 1996; 97: 833.
27. Azuma H, Chandraker A, Nadeau K, et al. Blockade of T-cell costimulation prevents development of experimental chronic allograft rejection. Proc Natl Acad Sci USA 1996; 93: 12439.
28. Sayegh MH, Akalin E, Hancock WW, et al. CD28-B7 blockade after alloantigen challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med 1995; 181: 1869.
29. Akalin E, Chandraker A, Russel ME, Turka LA, Hancock WW, Sayegh MH. CD28-B7 T cell costimulatory blockade by CTLA4Ig in the rat renal allograft model. Transplantation 1996; 62: 1942.
30. Schmid C, Binder J, Heemann U, Tilney NL. Successful heterotopic heart transplantation in the rat. Microsurgery 1994; 15: 279.
31. Hathcock KS, Laszlo G, Pucillo C, Linsley P, Hodes RJ. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J Exp Med 1994; 180: 631.
32. Peach RJ, Bajorath J, Brady W, et al. Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1. J Exp Med 1994; 180: 2049.
33. Sablinski T, Sayegh MH, Hancock WW, et al. Differential role of CD4+ cells in the sensitization and effector phases of accelerated graft rejection. Transplantation 1991; 51: 226.
34. Onodera K, Lehmann M, Akalin E, Volk HD, Sayegh MH, Kupiec-Weglinski JW. Induction of "infectious" tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients. J Immunol 1996; 157: 1944.
35. Baldwin WM III, Rhoton K, Sanfilippo F. IgM and IgG alloantibody production by splenocytes and deposition in rat renal allografts are decreased by donor-specific blood transfusion. Transplantation 1991; 51: 481.
36. Wallace PM, Johnson JS, MacMaster JF, Kennedy KA, Gladstone P, Linsley PS. CTLA4Ig treatment ameliorates the lethality of murine graft-versus-host disease across major histocompatibility complex barriers. Transplantation 1994; 58: 602.
37. Wallace PM, Rodgers JN, Leytze GM, Johnson JS, Linsley PS. Induction and reversal of long-lived specific unresponsiveness to a T-dependent antigen following CTLA4Ig treatment. J Immunol 1995; 154: 5885.
38. Gause WC, Mitro V, Via C, Linsley P, Urban JF, Greenwald RJ. Do effector and memory T helper cells also need B7 ligand costimulatory signals? J Immunol 1997; 159: 1055.
39. Schmidbauer G, Hancock WW, Wasowska B, Badger AM, Kupiec-Weglinski JW. Abrogation by rapamycin of accelerated rejection in sensitized rats by inhibition of alloantibody responses and selective suppression of intragraft mononuclear and endothelial cell activation, cytokine production, and cell adhesion. Transplantation 1994; 57: 933.
40. Binder J, Lehmann M, Graser E, et al. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts. Transplantation 1996; 61: 804.
41. Heidecke CD, Hancock WW, Jakobs F, et al. α/β-T cell receptor-directed therapy in rat cardiac allograft recipients. Transplantation 1995; 59: 78.
42. Bolling SF, Lin H, Wie RQ, Turka LA. Preventing allograft rejection with CTLA4Ig: effect of donor-specific transfusion route or timing. J Heart Lung Transplant 1996; 15: 928.
43. Hancock WW, Sayegh MH, Zheng XG, Peach R, Linsley PS, Turka LA. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. Proc Natl Acad Sci USA 1996; 93: 13967.
44. Pearson TC, Alexander DZ, Hendix R, et al. CTLA4-Ig plus bone marrow induces long-term allograft survival and donor-specific unresponsiveness in the murine model. Transplantation 1996; 61: 997.
45. Kearney ER, Walunas TL, Karr RW, et al. Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibition by CTLA-4. J Immunol 1995; 155: 1032.
46. Judge TA, Tang A, Spain LM, Gratiot-Deans J, Sayegh MH, Turka LA. The in vivo mechanisms of action of CTLA4Ig. J Immunol 1996; 156: 2294.
47. Linsley PS, Wallace PM, Johnson J, et al. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 1992; 257: 792.
48. Bradley JA. The blood transfusion effect: experimental aspects. Immunol Lett 1991; 29: 127.